Sierra Vista Regional Medical Center | |
1010 Murray St, San Luis Obispo, California 93405 | |
(805) 546-7600 | |
Name | Sierra Vista Regional Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 1010 Murray St, San Luis Obispo, California |
Ownership | Proprietary |
Emergency Services | Yes |
Medicare ID (CCN) | 050506 |
NPI Number | 1639101116 |
Organization Name | SIERRA VISTA HOSPITAL, INC. |
Doing Business As | SIERRA VISTA REGIONAL MEDICAL CENTER |
Address | 1010 Murray St, San Luis Obispo, CA 93405 |
Hospital Type | General Acute Care Hospital |
Phone Number | 805-546-7600 |
News Archive
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has completed its targeted enrollment of 60 patients in the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT™ in patients with non-squamous non-small cell lung cancer (NSCLC).
The results of a double-blind, randomized, multisite placebo-controlled trial that was conducted in South Africa show that Oxford's ChAdOx1 nCoV-19 (AZD1222) vaccine has no efficacy against the B.1.351 variant in preventing mild-to-moderate coronavirus disease 2019 (COVID-19), and shows reduced neutralization properties of developed antibodies. The findings are published in the New England Journal of Medicine.
The Robotic Surgery Center at NYU Langone Medical Center recently completed its second year offering monthly robotic surgery education sessions for minimally invasive robotic procedures.
Death rates from sepsis fell faster in New York than expected and faster than in peer states following the introduction of the nation's first state-mandated sepsis regulation, according to an analysis led by University of Pittsburgh researchers and published today in JAMA.
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
› Verified 4 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has completed its targeted enrollment of 60 patients in the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT™ in patients with non-squamous non-small cell lung cancer (NSCLC).
The results of a double-blind, randomized, multisite placebo-controlled trial that was conducted in South Africa show that Oxford's ChAdOx1 nCoV-19 (AZD1222) vaccine has no efficacy against the B.1.351 variant in preventing mild-to-moderate coronavirus disease 2019 (COVID-19), and shows reduced neutralization properties of developed antibodies. The findings are published in the New England Journal of Medicine.
The Robotic Surgery Center at NYU Langone Medical Center recently completed its second year offering monthly robotic surgery education sessions for minimally invasive robotic procedures.
Death rates from sepsis fell faster in New York than expected and faster than in peer states following the introduction of the nation's first state-mandated sepsis regulation, according to an analysis led by University of Pittsburgh researchers and published today in JAMA.
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
› Verified 4 days ago
French Hospital Medical Center Acute Care Hospital Location: 1911 Johnson Ave, San Luis Obispo, California 93401 Phone: (805) 543-5353 | |
Sierra Vista Regional Medical Center Acute Care Hospital Location: 1010 Murray St, San Luis Obispo, California 93405 Phone: (805) 546-7600 |